Fortress Biotech Inc.

02/24/2021 | Press release | Distributed by Public on 02/24/2021 07:06

Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a Wholly-owned Subsidiary of the Zydus Group, Sign Development and Asset Purchase Agreement[...]